EW

Edwards Lifesciences Corp
NYSE
69.18
+0.82
+1.20%
After Hours: 69.50 +0.32 +0.46% 17:21 12/04 EST
OPEN
68.36
PREV CLOSE
68.36
HIGH
69.97
LOW
68.03
VOLUME
4.43M
TURNOVER
0
52 WEEK HIGH
94.87
52 WEEK LOW
60.57
MARKET CAP
41.96B
P/E (TTM)
29.58
1D
5D
1M
3M
1Y
5Y
Morgan Stanley Maintains Overweight on Edwards Lifesciences, Lowers Price Target to $80
Benzinga · 23h ago
RBC Capital Keeps Their Buy Rating on Edwards Lifesciences (EW)
TipRanks · 1d ago
Edwards Lifesciences Corporation's (NYSE:EW) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Edwards lifesciences (nyse:ew) has a 21% return on equity. Return on equity is a measure of how much profit a company can generate from its assets. The company's net income growth over the last five years is 17%. Ew has a high roe of 21%, compared to an industry average of 9.5%. The company has a decent earnings growth rate of 21% over the past three years.
Simply Wall St · 1d ago
Weekly Report: what happened at EW last week (1127-1201)?
Weekly Report · 1d ago
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years
Edwards lifesciences has outperformed the market over the past 20 years by 10.52% on an annualized basis. Ew has an average annual return of 18.09%. Ew has a market capitalization of $41.26 billion. If an investor bought $100 of ew stock 20 years ago, it would be worth $2,723.92 today.
Benzinga · 3d ago
Catalyst Watch: McDonald's event, Lululemon earnings and GameStop volatility redux
Short interest levels pushed higher on faraday future intelligent electric and fisker. Options trading volume spiked on gamestop ahead of the retailer's earnings report. October factory orders report will be released on december 4. Notable investor events scheduled for next week include mcdonald's event, lululemon earnings.
Seeking Alpha · 3d ago
Buy Rating on Edwards Lifesciences: Resilience and Growth Potential Underscored by Stable TAVR Market Position
TipRanks · 4d ago
Analysts Forecast 11% Gains Ahead For IVV
NASDAQ · 6d ago
More
About EW
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including the Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. It conducts operations worldwide and is managed in various geographical regions, including the United States, Europe, Japan, and the Rest of the World. It sells products that are used to treat advanced cardiovascular disease in all regions.

Webull offers Edwards Lifesciences Corp stock information, including NYSE: EW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EW stock methods without spending real money on the virtual paper trading platform.